India to South Africa: Teicoplanin Export Trade Route

The India to South Africa Teicoplanin corridor is one of India's established pharmaceutical export routes, with 21 shipments documented worth a combined $1.1M USD. The route is dominated by GUFIC BIOSCIENCES LIMITED, which alone accounts for roughly 62% of all export value, reflecting the consolidated nature of India's teicoplanin manufacturing sector.

Across 3 active suppliers, the average shipment value stands at $53.7K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 83% of all shipments, consistent with teicoplanin's non-urgent bulk-order profile.

Shipment activity peaks during April–June, with an average transit time of 31 days port-to-port. The route has recorded an annual growth rate of 17.9%, placing it at rank #11 among India's top teicoplanin export destinations globally.

On the import side, key buyers of Indian teicoplanin in South Africa include AUSTELL PHARMACEUTICALS ( PTY) LTD, MEDPRO PHARMACEUTICA PTY LTD, AUSTELL PHARMACEUTICALS (PTY) LTD, and 3 others. AUSTELL PHARMACEUTICALS ( PTY) LTD is the single largest importer with 3 shipments valued at $357.5K USD.

India's teicoplanin exports to South Africa are driven primarily by a handful of large-scale manufacturers. GUFIC BIOSCIENCES LIMITED with 6 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 3 active exporters signals a competitive but concentrated market — buyers in South Africa benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — GUFIC BIOSCIENCES LIMITED, CIPLA LIMITED, GUFIC BIOSCIENCES LIMITED — together account for 100% of total trade value on this route. The average shipment value of $53.7K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.

Beyond the primary product category, shipments on this route include closely related formulations such as tegorid iv 400 mg ( teicoplanin 400 mg inj ) ( 31940 vials / $5.39 per vials ) and tegorid iv 400 (teicoplanin 400 mg inj) , suggesting that buyers in South Africa tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, AUSTELL PHARMACEUTICALS ( PTY) LTD is the largest importer with 3 shipments worth $357.5K USD — representing 32% of all teicoplanin imports from India on this route. A total of 6 buyers are active on this corridor.